EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients
Clinical trial NCT02652377 · COMPLETED
Trial details
- NCT number
- NCT02652377
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-10
- Primary completion
- 2016-12-27
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.